Case reports: red scrotal syndrome: a localized phenotypical expression of erythromelalgia.
We report a case of red scrotal syndrome responding to oral gabapentin, a neuropathic mediator that is commonly used in the treatment of primary erythromelalgia. The positive response to oral gabapentin and the resemblance of these 2 conditions supports that red scrotal syndrome is a phenotypical expression of localized primary erythromelalgia.
Prevost
Noel
N
University of Pittsburgh, Department of Dermatology, Pittsburgh, PA 15213, USA.
English
Joseph C
JC
D000284:Administration, Oral; D000588:Amines / Q000008:administration & dosage / Q000627:therapeutic use; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D004916:Erythromelalgia / Q000188:drug therapy* / Q000473:pathology; D000077206:Gabapentin; D005832:Genital Diseases, Male / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012611:Scrotum / Q000187:drug effects* / Q000473:pathology; D013577:Syndrome; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin